PPRS Update Quarter 4 2014 payments 13 th March 2015 David Watson Director Pricing and Reimbursement 1.

Slides:



Advertisements
Similar presentations
Understanding the NHS reforms Jo Webber, Deputy Policy Director 20 th March 2012.
Advertisements

Update from the ABPI Procurement and Distribution Interest Group 6 November 2014 Carol Blount NHS Partnerships Director.
The National Perspective
Healthy People, Healthy Lives Our strategy for public health in England.
ABPI Scotland: Medicines in Scotland. Membership body of the Pharmaceutical Industry – statutory negotiating body Represents majority of research based.
The Challenges for Medicines Optimisation
How can the Pharma Industry assist the NHS in constrained times? Can Pharma help with QIPP? PDIG meeting, 10 June 2010 Alison Clough Commercial & Communications.
1 Healthy Lives, Healthy People: a Public Health Workforce Strategy East Midlands Public Health Summit 17 June 2014.
The streamlined legal framework for looked after children Implementation of Care Planning and placements regulations and guidance November 2010.
The reforms: Opportunities for getting it right for children whose behaviour challenges Christine Lenehan Director.
Health and Wellbeing in Derby Derek Ward Joint Director of Public Health.
PAHO/WHO Seminar Brasilia October 2002 PAHO/WHO INTERNATIONAL SEMINAR ON CHALLENGES FOR COMPREHENSIVE PHARMACEUTICAL SERVICES BRASILIA, OCTOBER 2002 Experience.
(c) 2001 Contemporary Engineering Economics 1 Chapter 5 Understanding Money and Its Management Nominal and Effective Interest Rates Equivalence Calculations.
Health Policy and Social Enterprise in the UK
1 ABPI Vision and Narrative. Clinicians / Commissioners focused on outcomes and incentivised and remunerated on the results they achieve.
SEN and Disability Green Paper Update on draft legislation and pathfinder programme.
The Power of Shared Knowledge Wales’ 4th International Autism Conference 21st June – City Hall, Cardiff Hugh Morgan OBE,
SEN and Disability Green Paper Pathfinders March 2012 Update.
Building a care and support system we can be proud of Richard Jones Executive Director Lancashire County Council Oct 2011.
1 Richard Carter Head of Industry Sponsorship Department of Health London.
Efficiency and IT Panel SHARP Project Update Sept 2005 Hertfordshire County Council
Greater Manchester Strategy Rebecca Heron and Rod Fawcett GM Integrated Support Team 12 April 2013.
Health Overview Policy and Scrutiny Panel Update on Health Reform Proposals James Foster North Somerset Council.
DH PRICE CONTROLS Implications for the Future Pricing and Supply of Branded Medicines within NHS Hospitals.
TBS Seminar on Essential Medicines and Health Products Geneva, 29 October 2013 Matthew Jowett, PhD Senior Health Financing Specialist Dept. Health Systems.
The New Public Health System
Publisher financial planning Liz Ferguson Associate Publishing Director Wiley-Blackwell
Summary from the Economics Track With thanks to all track participants, presenters, rapporteurs, moderators and organizers.
PROCUREMENT & DISTRIBUTION INTEREST GROUP Autumn Symposium 2007
Independent Monitoring & Evaluation for Accountability Presented to Health Sector Steering Committee, 21 st July 2009.
1 REPORT OF:Joanne Newton DATE OF PAPER:26 June 2013 SUBJECT:Financial Position at 31 st May 2013 IN CASE OF QUERY, PLEASE CONTACTJoanne Newton Joanne.
Barriers to innovation – and solutions The Collaboration Conundrum Colette Goldrick, Director ABPI Northern Ireland.
SEN and Disability Green Paper: Update March
Public Behavioral Health Policy and Fiscal Updates California Institute for Mental Health (CiMH) Behavioral Health Financial Managers' Fiscal Leadership.
Health, Wellbeing and Social Care Scrutiny Committee.
ERCOT Financial Summary For the Month Ended September 30, 2005
PATIENTS IN RESEARCH RESEARCH CULTURE.
NHS Equality and Diversity Council Equality Delivery System (EDS) Maqsood Ahmad Director of NHS EDS Implementation Personal, Fair and Diverse.
Anthony Kealy Policy Directorate Commissioning Team Developing Commissioning Policy.
Breakthrough to real change in local healthcare Dr Patricia Hamilton Director of Medical Education.
Current Challenges and Future Developments in HTA in the UK Frances Macdonald, 23 rd September 2008 (A personal, Industry View)
BACKGROUND TO THE HEALTH AND WELLBEING STRATEGY Neil Revely.
NAFAO Conference 18 October 2012 David Hayward – Department of Health Universal Deferred Payments: Designing the new scheme.
Liberating the NHS : An Information Revolution Kathy Mason DH Informatics Directorate.
Dementia Prevalence Calculator Improving the diagnosis of dementia, and diagnosis pathways Kate Schneider, NHS South of England (West)
Social Fund Reform and the introduction of local provision in Scotland, Wales and England
1 Public hearing on conditional grants and capital expenditure: 3rd quarter Presentation to Select Committee on Finance Northern Cape’s Department of Agriculture.
Fisheries and Oceans Canada Presented By: Joanna Kilpatrick Associate Account Manager Date: May 14, 2008.
PROCUREMENT IN PRSCs – Case of Uganda March 24-28, 2008 Playing a Key Role in achieving the Development Results Playing a Key Role in achieving the Development.
Chris Horlick Managing Director Care, Partnership 17 th July 2013 Care Reform, opportunity or Risk?
3 rd Quarter 2004 Results Presentation A member of the Li & Fung (Retailing) Group 28 October 2004.
2 nd Quarter 2004 Results Presentation A member of the Li & Fung (Retailing) Group 4 August 2004.
Enterprise Directorate General European Commission The EU Framework for a Competitive Pharmaceutical Industry for the Benefit of the Patient European.
California Community Mental Health Revenue Update California Institute for Behavioral Health Solutions (CIBHS) County Behavioral Health Fiscal Leadership.
Strengthening the commitment
Update to NLAG board 22 nd December Sep Jan MCE Workforce and OD Oct Nov Dec IM&T Estates Finance In hospital Model Out of hospital Model Progress.
NHS Reform Update October Context Health Reform Agenda Significant pace of change Clear focus on supporting the Transition Process At the same time.
Joan Saddler National Director Patient and Public Affairs, DH and EDC Member.
NORTHERN NEW ENGLAND ACCOUNTABLE CARE COLLABORATIVE NNEACC 1 LD 1818 WORK GROUP David Wennberg August 9, 2012.
Leading Nottingham Programme update to ACOS 7 September 2010 Angela Probert Director of HR and Organisational Transformation Contributions from Lisa Sharples.
Care Act Care and Support Reforms Paul Taylor: Director Health, Wellbeing and Care.
Christopher M. Quinn, MACC, CPA, CFE, CGFO, CGMA Finance Director Tuesday, May 3 rd, 2016.
IPC & PHB expansion March Purpose This slide pack provides an update on the recently developed work programme to significantly.
Social Fund Reform and the introduction of local welfare provision in England
1 Presented to the City Council by Karen Montgomery Assistant City Manager February 17, 2009 UPDATE ON FY 2009 SALES TAX COLLECTIONS.
Appraisal and Funding of Cancer Drugs from July 2016 (including the new Cancer Drugs Fund) A new deal for patients, taxpayers and industry Tuesday 5 July.
National Immunoglobulin Database Meeting Procurement Update
2010 Nov 2011 January February March April May June July
Primary Care Sheffield
Commonwealth of Virginia
Presentation transcript:

PPRS Update Quarter payments 13 th March 2015 David Watson Director Pricing and Reimbursement 1

Q growth rate ABPI focus Communication to members Q & A Agenda 2

Q4 DH Publication £310M paid by industry in total for 2014 Measured spend: the spend controlled by the PPRS Payment mechanism. Included sales of new products Sales covered by the PPRS Payment: The percentage payment applies to these sales, which exclude sales of new products. Sales of new products are included in the calculation of the overall sum to be repaid across all member companies. Products with a new active substance designation that are introduced after 31 December 2013 are excluded from the sales used to calculate the payment by each company 3

4 Q4 DH Publication Growth for the full year 2014: 5.2%, down from the YTD Q3 growth of 5.93%

5 Q4 DH Publication Quarter versus Quarter growth lower at 3.2%

6 Q4 DH Publication The latest growth rate won’t change the 2015 payment,..but will be part of the calculation for the 2016 payment.

PPRS timelines*: 31 st Jan2014 Q4 sales report + payment 12 th MarchQ4 Data published 30 th April2015 Q1 sales report + payment 2 nd JuneQ1 Data published 31 st July2015 Q2 sales report + payment 3 rd SeptQ2 Data published 30 th Sept2014 audited sales reports due 31 st Oct2015 Q3 sales report + payment 9 th DecQ3 Data and 2016 % payment published *DH Publication plan Feb 2015

Summary: growth 8 1.Fourth quarter payments of £81 million means a total of £310 million paid by industry in 2014 to underwrite the medicines bill 2.Full year growth of 5.2% - less than the quarter three growth of 5.93%, but still represent growth above the original joint forecast of 3.87% 3.Last quarter growth much lower at 3.2%, Q will drive 2016 payment, scheme estimated 3.52% growth in New product share 0.55% - in line with estimates 5.Increased use of branded medicines is encouraging but industry would still like to see equal access for patients across care sectors

9 PPRS : platform for change Ensure delivery of commitments to improved access and uptake: ABPI working with the Department of Health, NHS England and government to ensure action in key areas: NICE, access and uptake, through formal reviews MISG – ABPI in working group with mandate to develop recommendations to unlock blockages in the NHS Advocacy focus with aligned industry positions e.g. Parliamentary debate on patient access Support planning: reforecast of medicines growth

Medicines Bill Projections (2015 – 2018) March Forecasting the market Step 1Step 2Step 3 Market trends analysis Medicine Market forecast Adapt the medicine market forecast to the PPRS framework

11 PPRS : company events All company PPRS workshops (tbc: 30th March, 13th and 29th April) Context for the current scheme Update on growth, forecast plans Progress with PPRS commitments NICE reform, CDF Finance Directors forum (11th March) Smaller Companies Forum (24th March)

Q & A